Jane Street Group, LLC Unity Biotechnology, Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$0.72 - $1.86 $31,110 - $80,368	-43,209 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$1.3 - $3.17 $56,171 - $136,972	43,209 New	43,209 $63,000
Q3 2021 Nov 16, 2021	SELL	$2.91 - $4.5 $63,016 - $97,447	-21,655 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.15 - $6.3 $89,868 - $136,426	21,655 New	21,655 $100,000
Q1 2021 May 18, 2021	SELL	$5.51 - $9.42 $567,023 - $969,393	-102,908 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$3.42 - $6.36 $206,684 - $384,360	60,434 Added 142.28%	102,908 $539,000
Q3 2020 Nov 17, 2020	BUY	$2.94 - $12.43 $124,873 - $527,951	42,474 New	42,474 $147,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $20.6M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.